NCT05605236View on ClinicalTrials.gov

Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 16, 2020

Primary Completion Date

May 16, 2022

Study Completion Date

July 16, 2022

Conditions
Bronchial Cancer
Trial Locations (1)

67091

Service de chirurgie thoracique - CHU de Strasbourg - France, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT05605236 - Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0) | Biotech Hunter | Biotech Hunter